Dose Escalation/Reduction
Reduced Starting Dose of Tyrosine Kinase Inhibitors in Patients with Metastatic Renal-Cell Carcinoma
Tia M. Stitt, PharmD; Katherine M. Saunders, PharmD, BCOP; Brooke C. Rowling, PharmD Candidate; Jennifer L. Waller, PhD; Amber B. Clemmons, PharmD, BCOP, FHOPA
Andrew Kowalski, PharmD, BCOP; Sara Mohamed Jaszczur, PharmD, BCOP; Michelle Nadeau-Nguyen, PharmD, BCPS; Man Yee Merl, PharmD, BCOP
Amany R. Keruakous, MD;
Sarah A. Schmidt, PharmD;
Marcus T. Autry, PharmD;
Julia Ye, PharmD Candidate;
Phoi Nguyen, PharmD Candidate;
Silas Day
Ekim Ekinci, PharmD, MS, BCOP; James E. Cox, PharmD, BCOP; Joe E. Ensor, PhD; Edward T. McLean, PharmD, BCOP; Carlos A. Ramos, MD; Premal D. Lulla, MD; Rammurti T. Kamble, MD; George Carrum, MD
Loriel J. Solodokin, PharmD, BCOP; Amir Steinberg, MD, FACP; Erin Moshier, MS
So Jung Uhm, PharmD; John Malamakal, PharmD, MS, BCPS, BCOP
Volkmar Böhme, MD; Ee Min Yeoh, BSc Pharm
Erin K. Yeung, PharmD, BCPS; John Malamakal, PharmD, MS, BCPS, BCOP
Results 1 - 9 of 9